Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Non-Current Debt (2020 - 2021)

Silo Pharma's Non-Current Debt history spans 2 years, with the latest figure at $1063.0 for Q1 2021.

  • For Q1 2021, Non-Current Debt changed N/A year-over-year to $1063.0; the TTM value through Mar 2021 reached $1063.0, changed N/A, while the annual FY2020 figure was $4246.0, N/A changed from the prior year.
  • Non-Current Debt for Q1 2021 was $1063.0 at Silo Pharma, down from $4246.0 in the prior quarter.
  • Across five years, Non-Current Debt topped out at $11642.0 in Q2 2020 and bottomed at $1063.0 in Q1 2021.